Chemesis International Inc. (CSE:CSI, OTCQB:CADMF) (the “Company” or “Chemesis”), pronounces it has acquired Viverian, a hemp-derived CBD product line that promotes healthy dwelling and offers shoppers with fast and straightforward strategies of consumption.
Chemesis International Inc. (CSE:CSI, OTCQB:CADMF) (the “Company” or “Chemesis”), pronounces it has acquired Viverian, a hemp-derived CBD product line that promotes healthy dwelling and offers shoppers with fast and straightforward strategies of consumption. This CBD unique model is offered through a web-based e-commerce platform with present distribution in Arizona, Nevada and Florida. The Company will broaden right into a retail technique and extra states for on-line delivery in 2019, as soon as state-by-state rules have been established for CBD manufacturing and distribution.
For extra info on the merchandise, please go to www.viverian.com.
The product line contains CBD tinctures, in addition to capsules that will help with sleep, leisure, improved focus, aid for discomfort, and improved general health and wellness. These merchandise have been lab examined, are THC free, and made from 100% botanical elements. Chemesis has secured third-party GMP licensed manufacturing for these merchandise.
The anticipated passing of the U.S. 2018 Farm Bill offers additional readability for hemp derived CBD merchandise on a federal degree. Current estimates present the CBD market might develop to over $2.1 billion by 2020, with $450 million in gross sales coming from hemp-based sources1. The invoice is in its remaining stage, having already handed each the Senate and the U.S. House of Representatives, making this a big acquisition for the Company.2
“We are extremely excited to bring on a high-quality CBD product catalogue for consumers that is THC free,” stated Edgar Montero, CEO of Chemesis. “With the expected passing of the Farm Bill, we believe we are positioning the Company to take advantage of increasing demand for high quality hemp derived CBD products.”
As a part of this acquisition for the Viverian product line, the Company can pay US$500,000 in stock priced on the shut of December 14, 2018. The stock shall be topic to a 36-month escrow launch schedule.
On Behalf of The Board of Directors
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically built-in international chief within the hashish business, at present working inside California, Puerto Rico, and finalizing acquisition in Colombia.
Chemesis is growing a robust foothold in key markets, from cultivation, to manufacturing, distribution, and retail. Chemesis has services in each Puerto Rico and California, permitting for value efficient manufacturing and distribution of its merchandise. In addition, Chemesis leverages unique manufacturers and partnerships and makes use of the best high quality extraction strategies, to offer shoppers with high quality hashish merchandise.
Chemesis will add shareholder worth by exploring alternatives in rising markets whereas persistently delivering high quality product to its shoppers from seed to sale.
1 (604) 398-3378
Forward-Looking Information: This information launch accommodates “forward-looking information” throughout the which means of relevant securities legal guidelines regarding statements relating to the Company’s enterprise, merchandise and future the Company’s enterprise, its product choices and plans for gross sales and advertising. Although the Company believes that the expectations mirrored within the forward-looking info are cheap, there could be no assurance that such expectations will show to be appropriate. Readers are cautioned to not place undue reliance on forward-looking info. Such forward-looking statements are topic to dangers and uncertainties that will trigger precise outcomes, efficiency and developments to vary materially from these contemplated by these statements relying on, amongst different issues, the dangers that the Company’s merchandise and plan will range from these said on this information launch and the Company might not be capable to perform its enterprise plans as anticipated. Except as required by regulation, the Company expressly disclaims any obligation and doesn’t intend, to replace any forward-looking statements or forward-looking info on this information launch. Although the Company believes that the expectations mirrored within the forward-looking info are cheap, there could be no assurance that such expectations will show to be appropriate and makes no reference to profitability based mostly on gross sales reported. The statements on this information launch are made as of the date of this launch.
The CSE has not reviewed, authorized or disapproved the content material of this press launch